<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T02:31:38Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:10162659" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:10162659</identifier>
        <datestamp>2023-05-05</datestamp>
        <setSpec>nihpa</setSpec>
        <setSpec>pmc-open</setSpec>
        <setSpec>manuscript</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-journal-id">101654592</journal-id>
              <journal-id journal-id-type="pubmed-jr-id">43691</journal-id>
              <journal-id journal-id-type="nlm-ta">Clin Nutr ESPEN</journal-id>
              <journal-id journal-id-type="iso-abbrev">Clin Nutr ESPEN</journal-id>
              <journal-title-group>
                <journal-title>Clinical nutrition ESPEN</journal-title>
              </journal-title-group>
              <issn pub-type="epub">2405-4577</issn>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC10162659</article-id>
              <article-id pub-id-type="pmcid">PMC10162659</article-id>
              <article-id pub-id-type="pmc-uid">10162659</article-id>
              <article-id pub-id-type="pmid">36184194</article-id>
              <article-id pub-id-type="pmid">36184194</article-id>
              <article-id pub-id-type="doi">10.1016/j.clnesp.2022.07.004</article-id>
              <article-id pub-id-type="manuscript">nihpa1884232</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Article</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Essential amino acid enriched meal replacement improves body composition and physical function in obese older adults: A randomized controlled trial</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Coker</surname>
                    <given-names>Melynda S.</given-names>
                  </name>
                  <xref rid="A1" ref-type="aff">a</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Barati</surname>
                    <given-names>Zeinab</given-names>
                  </name>
                  <xref rid="A2" ref-type="aff">b</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Murphy</surname>
                    <given-names>Carl J.</given-names>
                  </name>
                  <xref rid="A2" ref-type="aff">b</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Bateman</surname>
                    <given-names>Terry</given-names>
                  </name>
                  <xref rid="A2" ref-type="aff">b</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Newcomer</surname>
                    <given-names>Bradley R.</given-names>
                  </name>
                  <xref rid="A3" ref-type="aff">c</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Wolfe</surname>
                    <given-names>Robert R.</given-names>
                  </name>
                  <xref rid="A4" ref-type="aff">d</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Coker</surname>
                    <given-names>Robert H.</given-names>
                  </name>
                  <xref rid="A1" ref-type="aff">a</xref>
                  <xref rid="CR1" ref-type="corresp">*</xref>
                </contrib>
              </contrib-group>
              <aff id="A1"><label>a</label>Montana Center for Work Physiology and Exercise Metabolism, University of Montana, Missoula, MT, USA</aff>
              <aff id="A2"><label>b</label>Institute of Arctic Biology, University of Alaska Fairbanks, Fairbanks, AK, USA</aff>
              <aff id="A3"><label>c</label>Honors College, James Madison University, Harrisonburg, VA, USA</aff>
              <aff id="A4"><label>d</label>Donald W. Reynolds Institute on Aging, University of Arkansas for Medical Sciences, Little Rock, AR, USA</aff>
              <author-notes>
                <corresp id="CR1"><label>*</label>Corresponding author: <email>robert.coker@umontana.edu</email> (R.H. Coker).</corresp>
              </author-notes>
              <pub-date pub-type="nihms-submitted">
                <day>1</day>
                <month>4</month>
                <year>2023</year>
              </pub-date>
              <pub-date pub-type="ppub">
                <month>10</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="epub">
                <day>20</day>
                <month>7</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>05</day>
                <month>5</month>
                <year>2023</year>
              </pub-date>
              <volume>51</volume>
              <fpage>104</fpage>
              <lpage>111</lpage>
              <permissions>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref>
                  <license-p>This is an open access article under the CC BY-NC-ND license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>).</license-p>
                </license>
              </permissions>
              <abstract id="ABS1">
                <title>SUMMARY</title>
                <sec id="S1">
                  <title>Background:</title>
                  <p id="P1">Older adults are threatened by the risk of muscle atrophy and excess accumulation of adipose tissue. The objective of this study was to determine whether an essential amino acid enriched meal replacement would reduce excess fat and foster skeletal muscle retention, potentially improving physical function in this cohort.</p>
                </sec>
                <sec id="S2">
                  <title>Methods:</title>
                  <p id="P2">Using a double blind, randomized controlled trial, we compared the influence of an experimental meal replacement enriched with essential amino acids (EMR) to a commercially available, widely used meal replacement (Optifast<sup>®</sup>) provided once/day (q.d.) for four weeks on body composition, skeletal muscle and physical function in obese older participants. Twenty-eight individuals completed either EMR (n = 13) or Optifast<sup>®</sup> (n = 15) supplementation protocols. Measurements of body composition, thigh skeletal muscle cross-sectional area (CSA), blood panels, intrahepatic lipid, and physical function were completed pre- and post-supplementation.</p>
                </sec>
                <sec id="S3">
                  <title>Results:</title>
                  <p id="P3">Body fat mass, visceral fat mass and volume, and intrahepatic lipid were reduced with EMR but not with Optifast<sup>®</sup>. Thigh muscle CSA increased (Δ 2.4 ± 3.0 cm<sup>2</sup>) with EMR but not Optifast<sup>®</sup> (Δ −1.8 ± 6.0 cm<sup>2</sup>). There was a significant increase in the distance covered during the 6-min walk test with EMR (Δ 23 ± 27 m) but no change in Optifast<sup>®</sup> (Δ 11 ± 37 m).</p>
                </sec>
                <sec id="S4">
                  <title>Conclusions:</title>
                  <p id="P4">Beneficial alterations in fat and muscle support the use of EMR-based meal replacements in obese older adults.</p>
                </sec>
                <sec id="S5">
                  <title>Clinical Trial Registration:</title>
                  <p id="P5">ISRCTN registry under Reference Number <ext-link xlink:href="http://www.isrctn.com/ISRCTN15814848" ext-link-type="uri">ISRCTN15814848</ext-link>.</p>
                </sec>
              </abstract>
              <kwd-group>
                <kwd>Body composition</kwd>
                <kwd>Functional performance</kwd>
                <kwd>Muscle</kwd>
                <kwd>Nutrition</kwd>
              </kwd-group>
            </article-meta>
          </front>
          <body>
            <sec id="S6">
              <label>1.</label>
              <title>Introduction</title>
              <p id="P6">The progressive, deleterious loss of muscle mass that occurs with aging is called sarcopenia [<xref rid="R1" ref-type="bibr">1</xref>]. Muscle atrophy in conjunction with obesity is particularly problematic, as the load required for functional independence is increased, but with depleted contractile [<xref rid="R2" ref-type="bibr">2</xref>]. Age related accumulation of adipose tissue has been linked to decreased mitochondrial function, lipid infiltration into muscle and liver, chronic inflammation and insulin resistance (3). It is not surprising that sarcopenic obesity has also been associated with the development of metabolic diseases [<xref rid="R3" ref-type="bibr">3</xref>]. In other words, the concomitant presentation of muscle atrophy and obesity simultaneously conflates the consequences of reduced physical activity in individuals who are already at high risk. While losing weight might seem like the obvious solution, data from epidemiological studies suggest an obesity paradox by which body weight has a protective effect against mortality [<xref rid="R4" ref-type="bibr">4</xref>]. The efficacy of weight loss in addressing sarcopenic obesity is further complicated by low fitness levels in older, obese adults [<xref rid="R5" ref-type="bibr">5</xref>]; not surprisingly co-mingled with low interest in physical activity as a viable intervention [<xref rid="R6" ref-type="bibr">6</xref>]. Moreover, most individuals, prefer dietary modification as their only strategy to improve body composition and overall health [<xref rid="R6" ref-type="bibr">6</xref>].</p>
              <p id="P7">In addition to the connection between sarcopenic obesity and metabolic syndrome that may affect almost 50% of individuals over the age of 60 [<xref rid="R5" ref-type="bibr">5</xref>], inadequate nutritional intake can be a significant concern as well [<xref rid="R7" ref-type="bibr">7</xref>]. For example, a decline in the quality of the diet can lead to suboptimal body composition and further exacerbate the risks of disability among older adults [<xref rid="R8" ref-type="bibr">8</xref>]. To address these concerns, many individuals and health care providers utilize meal replacements to help maintain body weight and functional independence [<xref rid="R9" ref-type="bibr">9</xref>]. While the use of standard meal replacements like Optifast<sup>®</sup> may be effective for weight management in young to middle-aged populations [<xref rid="R10" ref-type="bibr">10</xref>], it is quite possible that the overall efficacy of standard meal replacements may be limited by the presence of anabolic resistance in older individuals [<xref rid="R11" ref-type="bibr">11</xref>].</p>
              <p id="P8">The acute benefits of a meal replacement enriched with essential amino acids (EAAs) compared to standard meal replacements on whole body net protein balance under isocaloric conditions in older individuals have been previously established [<xref rid="R12" ref-type="bibr">12</xref>]. In these studies that incorporated stable isotope methodology, higher net protein balance was influenced by the provision of specific amounts of EAAs and non-essential amino acids required for overcoming anabolic resistance [<xref rid="R13" ref-type="bibr">13</xref>]. The popularity of meal replacements is widespread, and the use of dietary strategies to improve overall health is broad. However, longitudinal, well-controlled evaluations designed to study the efficacy of EAA-based meal replacements on metabolic health and physical function in older individuals are sparse. Using a randomized controlled trial study design and a per protocol analytical approach, we tested the hypothesis that once/day (q.d.) consumption of an EAA-enriched meal replacement (EMR) would promote improvements in body composition, skeletal muscle, intrahepatic lipid, and physical function compared to an isocaloric commercially available meal replacement (i.e., Optifast<sup>®</sup>) in obese older individuals (see <xref rid="T1" ref-type="table">Table 1</xref> for Nutritional Composition of EMR and Optifast<sup>®</sup>).</p>
            </sec>
            <sec id="S7">
              <label>2.</label>
              <title>Methodology</title>
              <sec id="S8">
                <label>2.1.</label>
                <title>Recruitment</title>
                <p id="P9">We posted informational flyers and newsletters on the University of Alaska Fairbanks (UAF) campus. We also held brief informational presentations for the purpose of educating seniors in our community, providing them with an opportunity to participate in the study described herein. Individuals from all racial, ethnic, and/or cultural backgrounds between the ages of 60–85 years old with a body mass index of 26–40 kg/m<sup>2</sup> were encouraged to participate. Anyone interested in the trial was encouraged to call our secure, telephone answering service, which allowed private and individual telephone conversations to assess eligibility.</p>
                <p id="P10">This study was powered to evaluate changes in body composition in an obese older cohort based on the energy cost of EMR-induced alterations in protein metabolism [<xref rid="R14" ref-type="bibr">14</xref>]. Therefore, no attempt was made to stratify participants according to age or gender. The project (Nutrient Strategies for Muscle Preservation: 986801-17) and all related documents were approved on 17 September 2017 by the UAF Institutional Review Board. Recruitment began on 18 September 2017 and ended on 31 October 2018. All participants provided written informed consent prior to participation. Our randomized controlled trial is listed with the International Stand Randomised Controlled Trial Number (ISRCTN) registry under Reference Number <ext-link xlink:href="http://www.isrctn.com/ISRCTN15814848" ext-link-type="uri">ISRCTN15814848</ext-link>. The ISRCTN registry is recognized by the World Health Organization and the International Committee of Medical Journal Editors.</p>
              </sec>
              <sec id="S9">
                <label>2.2.</label>
                <title>Exclusion criteria</title>
                <p id="P11">Individuals with a pacemaker or other implanted metal device or object, or who had been previously diagnosed with insulin dependent diabetes, active cancer or malignancy, or a chronic inflammatory condition were excluded. Individuals taking medications, supplements, or corticosteroids that might have influenced metabolism were not enrolled. Finally, any individual with a disease or condition that would have placed them at risk or caused harm to themselves or others were also excluded. Participants were weight stable and not participating in a weight loss or exercise program at the time of enrollment.</p>
              </sec>
              <sec id="S10">
                <label>2.3.</label>
                <title>Study participants</title>
                <p id="P12">The participants were screened over the phone for basic inclusion/exclusion criteria. If accepted, the participants underwent additional screening via a health history questionnaire and anthropometric measurements by the study staff. We assessed fifty-three participants for eligibility by telephone screening. Once individuals were deemed eligible for participation, we enrolled thirty-seven obese older males and females of all races and ethnic backgrounds into a double blind, parallel, randomized controlled trial (<xref rid="F1" ref-type="fig">Fig. 1</xref>) (<xref rid="T2" ref-type="table">Table 2</xref>). A computerized, random number generator was used for group assignment. Two individuals whose body mass index (BMI) was slightly outside the range (ie., 43 and 44 kg/m<sup>2</sup>) were inadvertently enrolled and randomized for participation. This protocol deviation was reported to the Institutional Review Board at UAF. An individual not affiliated with the study or the academic program was responsible for blinding of the meal replacements. All researchers including our biostatistician (Dr. Barati) were blinded to treatment assignment. Study codes were unblinded following the completion of all statistical analysis.</p>
                <p id="P13">Based on random assignment, participants were asked to consume either EMR or Optifast<sup>®</sup> once/day for 4 weeks in lieu of their lunch time meal. Given that the meal replacements contained 160 calories, this likely resulted in a reduction in caloric intake at least for the lunch meal itself. Thirteen individuals completed their EMR assignment. Fifteen individuals completed their Optifast<sup>®</sup> assignment. Compliance was measured weekly using the weigh-back method, in which the researchers measured the weight of the product consumed and divided that by the weight that should have been consumed. Compliance to protocol was evaluated in all study participants, and the potential differences between EMR and Optifast<sup>®</sup> were analyzed. Using these compliance assessment strategies, twenty-seven of the participants were 80% or more compliant, with one participant being 55% compliant. There were no significant differences in compliance between the two groups.</p>
                <p id="P14">We made no attempt to modify any other aspect of dietary intake or suggest any alteration in physical activity to our participants. Of the twenty-two participants randomized to EMR, two were lost to follow-up, five withdrew due to the taste of EMR, and one withdrew due to an unrelated illness. Thirteen participants completed EMR and fifteen participants completed Optifast<sup>®</sup>. Three participants failed to complete their post-intervention MRI/MRS-derived scans for intrahepatic lipid; two were assigned to EMR and one was assigned to Optifast<sup>®</sup>. The MRI image for thigh muscle CSA contained artifacts (possibly due to excessive movement) in one of the participants assigned to Optifast<sup>®</sup> and was not available for pre- or post-supplementation analysis. The nutritional composition of the meal replacements is provided in <xref rid="T1" ref-type="table">Table 1</xref>.</p>
                <p id="P15">During pre- and post-supplementation study visits, participants completed the following: a) measurement of body weight and height, b) measurement of body composition, c) measurement of skeletal muscle cross-sectional area (CSA) of the upper thigh and intrahepatic lipid, c) physical function testing, and d) blood sampling/analysis for hepatic, lipid, and metabolic panels as described in detail below. All procedures were performed in the Clinical Research and Imaging Facility on the UAF campus except for blood sampling/analysis which was performed by LabCorp (1626, 30th Avenue, Fairbanks, AK). Participants returned once each week for research staff to record their body weight and the weight of any leftover EMR or Optifast<sup>®</sup> product, and to provide refills of their respective meal replacement. Participants refrained from alcohol consumption (24 h) and intense physical activities (72 h) prior to pre- and post-supplementation study visits. The study was conducted in accordance with the Declaration of Helsinki, and the protocol (#1427567-12) was approved by the UAF Institutional Review Board.</p>
              </sec>
              <sec id="S11">
                <label>2.4.</label>
                <title>Body composition</title>
                <p id="P16">Body mass and height was measured using an electronic scale/stadiometer (Health-o-Meter, St. McCook, IL, USA). Fat mass, lean tissue mass, visceral fat mass, and bone mineral content was provided by dual energy x-ray absorptiometry (DXA) scans (General Electric Lunar iDXA; Madison, WI).</p>
              </sec>
              <sec id="S12">
                <label>2.5.</label>
                <title>Magnetic resonance imaging/spectroscopy</title>
                <p id="P17">The CSA of the skeletal muscles in the thigh were imaged, and intrahepatic lipid was isolated and analyzed using molecular imaging/spectroscopy (MRI/MRS) (Toshiba Excelart/Vantage 1.5 T MRI/MRS imaging system; Canon, Ōtawara, Tochigi, Japan). Seven slices of thigh muscle CSA were imaged, quantified, and averaged using Osirix (Geneva, Switzerland) [<xref rid="R15" ref-type="bibr">15</xref>]. Determination of intrahepatic lipid was performed in our laboratory as previously described [<xref rid="R12" ref-type="bibr">12</xref>].</p>
              </sec>
              <sec id="S13">
                <label>2.6.</label>
                <title>Physical function</title>
                <p id="P18">Study participants were familiarized with functional tests prior to any performance or measurements of grip strength, floor transfer time, or walking distance/speed. Participants were instructed to perform their grip strength measurements three times per hand using the hand-held dynamometer (Lafayette Instrument, Lafayette, IN), in kilograms, was obtained from averaging the second and third attempts for each hand. For the floor transfer test, we measured the amount of time required to move from a standing position to a supine position and back up to a complete standing position [<xref rid="R14" ref-type="bibr">14</xref>]. Prior to the 6-min walk test, the participant was instructed to walk as fast as possible without assistance for the entire 6-min period in an unobstructed hallway. Time was recorded in meters/second obtained using a stopwatch [<xref rid="R14" ref-type="bibr">14</xref>].</p>
              </sec>
              <sec id="S14">
                <label>2.7.</label>
                <title>Blood measurements</title>
                <p id="P19">Sampling and analysis of all metabolic, lipid, and hepatic blood panels were performed by LabCorp (1626, 30th Avenue, Fairbanks, AK) as previously described [<xref rid="R12" ref-type="bibr">12</xref>].</p>
              </sec>
              <sec id="S15">
                <label>2.8.</label>
                <title>Sample size calculation</title>
                <p id="P20">We conducted a priori power analysis using G*Power software [<xref rid="R14" ref-type="bibr">14</xref>] to calculate the required number of participants for each group [<xref rid="R16" ref-type="bibr">16</xref>]. A sample size of 6 individuals per group was determined to achieve 80% power for detecting an effect size (Cohen’s d) of 1.62, which was determined based on our previous study demonstrating a significant reduction in adipose tissue after an 8-week weight loss intervention with EMR meal replacement [<xref rid="R17" ref-type="bibr">17</xref>]. Based on our experience with previous studies, we anticipated a dropout rate of ~20%.We determined that if 14 participants were enrolled for each intervention, our study would have enough power to detect effect sizes in adipose tissue as small as 0.95 (Cohen’s d).</p>
              </sec>
              <sec id="S16">
                <label>2.9.</label>
                <title>Statistical analysis</title>
                <p id="P21">Statistical analyses were conducted using IBM SPSS Statistics for Windows, Version 25.0. Armonk, NY: IBM Corp. The significance criterion was set to α &lt; 0.05 for all analyses and because of the exploratory nature of this study, no adjustment was made for multiple comparisons. In order to evaluate whether intervention based alterations in dependent variables were significantly different between groups, we normalized all variables by subtracting pre-supplementation from post-supplementation values. Data are shown as mean ± SD, unless otherwise indicated. We tested the normality assumption for all outcome variables using the Kolmogorov–Smirnov test. For normally distributed variables, independent samples t-tests for comparing EMR and Optifast<sup>®</sup> or paired samples t-tests for comparing baseline and post-intervention were used. If the normality assumption was violated, a non-parametric test, i.e. Mann–Whitney U test for independent samples or Wilcoxon Matched-Pairs Signed Ranks test for paired samples, was used.</p>
              </sec>
            </sec>
            <sec id="S17">
              <label>3.</label>
              <title>Results</title>
              <sec id="S18">
                <label>3.1.</label>
                <title>Research participants</title>
                <p id="P22">Twenty-eight obese older individuals completed 4 weeks of isocaloric q.d. ingestion of either EMR (containing 16 g of individual EAAs and 6 g of intact protein) (n = 13) or Optifast<sup>®</sup> (containing 16 g of intact protein) (n = 15) (<xref rid="T1" ref-type="table">Table 1</xref>) and completed testing related to body composition and physical function.</p>
              </sec>
              <sec id="S19">
                <label>3.2.</label>
                <title>Body composition</title>
                <p id="P23">There were no differences in baseline measurements of body composition (<xref rid="T2" ref-type="table">Table 2</xref>). Body weight, fat mass, visceral fat mass, and visceral fat volume were reduced in EMR but not in Optifast<sup>®</sup>. Lean tissue mass was not influenced by EMR or Optifast<sup>®</sup> (<xref rid="T2" ref-type="table">Table 2</xref>).</p>
              </sec>
              <sec id="S20">
                <label>3.3.</label>
                <title>Skeletal muscle</title>
                <p id="P24">Baseline thigh muscle CSA was not different (t = −0.62, <italic toggle="yes">p</italic> = 0.54) between EMR (134 ± 30 cm<sup>2</sup>) and Optifast<sup>®</sup> (142 ± 34 cm<sup>2</sup>). When thigh muscle CSA was subtracted from baseline (ie., post-pre), there was a significant difference (t = 2.26, <italic toggle="yes">p</italic> = 0.03) between EMR (Δ +2.4 ± 3.1 cm<sup>2</sup>) and Optifast<sup>®</sup> (Δ −1.8 ± 6.0 cm<sup>2</sup>) (<xref rid="F2" ref-type="fig">Fig. 2</xref>).</p>
              </sec>
              <sec id="S21">
                <label>3.4.</label>
                <title>Liver lipid</title>
                <p id="P25">Baseline MRI/MRS-derived intrahepatic lipid was not different (t = 0.64, <italic toggle="yes">p</italic> = 0.053) between EMR and Optifast<sup>®</sup>. There was a significant reduction in MRI/MRS-derived intrahepatic lipid with EMR (<italic toggle="yes">p</italic> = 0.04) and no change (<italic toggle="yes">p</italic> = 0.39) with Optifast<sup>®</sup> (<xref rid="F3" ref-type="fig">Fig. 3</xref>).</p>
              </sec>
              <sec id="S22">
                <label>3.5.</label>
                <title>Physical function</title>
                <p id="P26">There were no significant differences in baseline grip strength (kilograms), floor transfer test (seconds), or 6-min walk (meters) between the two groups. No changes in grip strength occurred with EMR or Optifast<sup>®</sup> (<xref rid="T3" ref-type="table">Table 3</xref>). The time required to perform the floor transfer test was reduced in EMR and presented a trend towards improvement in Optifast<sup>®</sup> (<xref rid="T3" ref-type="table">Table 3</xref>). There was a significant increase in the distance covered during the 6-min walk test and walking speed with EMR but no change in Optifast<sup>®</sup> (<xref rid="T3" ref-type="table">Table 3</xref>).</p>
              </sec>
              <sec id="S23">
                <label>3.6.</label>
                <title>Blood parameters</title>
                <p id="P27">Blood lipids were represented by total cholesterol, high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, and triglycerides. Hepatic function was characterized by protein, albumin, total bilirubin, direct bilirubin, alkaline phosphatase, aspartate aminotransferase, and alanine aminotransferase. The metabolic panel was expressed by glucose, blood urea nitrogen, creatinine, blood urea nitrogen/creatinine, and eGFR. All baseline blood parameters were within normal limits in both groups and not affected by supplementation except for protein, albumin, and blood urea nitrogen which increased in EMR (<xref rid="T4" ref-type="table">Table 4</xref>).</p>
              </sec>
            </sec>
            <sec id="S24">
              <label>4.</label>
              <title>Discussion</title>
              <p id="P28">The purpose of this study was to evaluate whether consumption of EMR q.d. for 4 weeks would improve body composition in obese older individuals. Our primary conclusion is that the EMR q.d. increased thigh muscle CSA and reduced total adipose tissue mass, visceral adipose tissue and intrahepatic lipid. These beneficial changes also occurred in conjunction with marginal improvements in the 6-min walk test and the floor transfer test. There were no significant changes in thigh muscle CSA adipose tissue in Optifast©. Overall, EMR was primarily effective in promoting positive changes in body composition and skeletal muscle in obese older adults.</p>
              <p id="P29">The superior influence of EMR on whole body protein synthesis, protein breakdown, and net protein balance compared to a high protein meal replacement (ie., Bariatric Advantage) in obese older adults has been demonstrated using stable isotope methodology [<xref rid="R14" ref-type="bibr">14</xref>]. In these acute feeding studies using a randomized, cross-over design, the initial “proof of concept” was developed to hypothesize the physiological outcomes described herein. The profile of EAAs in EMR was formulated to optimize translation of protein synthesis and overcome anabolic resistance in the context of aging without a concomitant increase in calories [<xref rid="R18" ref-type="bibr">18</xref>]. Therefore, the daily provision of EMR over the course of 4 weeks provided the requisite nutrient-induced stimulus to promote thigh skeletal muscle accretion in obese older individuals. This beneficial alteration in musculature with EMR occurred without any change in physical activity or additional dietary manipulation. Unlike the potentially complicated use of growth hormone, testosterone, or other pharmaceutical approaches in medical practice [<xref rid="R19" ref-type="bibr">19</xref>], consumption of EMR q.d. can be self-administered in otherwise healthy, obese individuals. With the exception of modest fluctuations in total protein and blood urea nitrogen, markers of hepatic and kidney function were within normal limits at baseline and did not change over the course of the 4-week study with the consumption of either EMR or Optifast<sup>®</sup>.</p>
              <p id="P30">MRI-, or computed tomography - derived measurement of thigh muscle CSA represents the gold standard for the evaluation of muscle mass, as these methods are near identical when compared to cadaveric data [<xref rid="R20" ref-type="bibr">20</xref>]. Therefore, the significant increase in thigh muscle CSA in EMR is particularly compelling. It is our assertion that EMR provides the requisite EAAs to overcome anabolic resistance. This may be facilitated by the optimization of intracellular translation in conjunction with the delivery of amino acid precursors needed to support optimal protein balance [<xref rid="R18" ref-type="bibr">18</xref>,<xref rid="R21" ref-type="bibr">21</xref>]. Combined with reductions in adipose tissue, increased thigh muscle CSA in those receiving EMR may have been translated to marginal improvements in the 6-min walk test and the floor transfer test; both of which have been closely associated with independent living in older adults [<xref rid="R22" ref-type="bibr">22</xref>,<xref rid="R23" ref-type="bibr">23</xref>]. Larger studies are warranted to explore the relationship between the provision of EAAs and improvements in physical function.</p>
              <p id="P31">The reduction in whole body and visceral adipose tissue in the EMR group may have been modestly linked to the energy cost of accelerated protein synthesis [<xref rid="R24" ref-type="bibr">24</xref>]. For example, 20 kcals are used for every 1 mol of amino acids incorporated into muscle protein [<xref rid="R25" ref-type="bibr">25</xref>]. Based on a theoretical calculation using data from our previous isotope study, the stimulation of protein synthesis resulting from a single serving of EMR multiplied by 30 days would only account for an increased expenditure of 1596 ± 143 kcals. It is likely that the provision of EMR several times throughout the day and/or as part of a caloric restriction strategy would be even more beneficial in promoting reductions in adipose tissue.</p>
              <p id="P32">In addition to our concerns related to sarcopenic obesity, we are aware that non-alcoholic fatty liver disease (NAFLD) has reached epidemic proportions in older adults [<xref rid="R26" ref-type="bibr">26</xref>]. Closely associated with insulin resistance and metabolic syndrome, NAFLD contributes to metabolic dysregulation and can lead to nonalcoholic steatohepatitis, putting individuals at an increased risk for fibrosis, cirrhosis, and liver failure [<xref rid="R27" ref-type="bibr">27</xref>]. While the precise effects of increased amino acid intake upon NAFLD are still unclear, previous work has demonstrated that 11 g of EAAs provided twice daily reduced intrahepatic lipid and plasma lipids [<xref rid="R28" ref-type="bibr">28</xref>]. Pre-clinical studies suggest that energy requirements for amino acid metabolism may enhance the oxidation of intrahepatic lipid [<xref rid="R29" ref-type="bibr">29</xref>]. While some studies have suggested an association between elevated branched chain amino acid concentrations and insulin resistance [<xref rid="R30" ref-type="bibr">30</xref>–<xref rid="R32" ref-type="bibr">32</xref>], recent pre-clinical studies suggest that branched chain amino acids may foster reductions in liver fat through permissive alterations in the gut microbiome and portal acetic acid levels [<xref rid="R33" ref-type="bibr">33</xref>]. Without any detrimental alterations in metabolic parameters, there was a significant reduction in intrahepatic lipid with once/day supplementation of EAAs in the form of EMR (<xref rid="F3" ref-type="fig">Fig. 3</xref>). Our results are consistent with literature in which branched chain amino acids were given to older individuals diagnosed with underlying etiology metabolic syndrome that may have included hepatic steatosis, without inducing or worsening insulin resistance [<xref rid="R34" ref-type="bibr">34</xref>,<xref rid="R35" ref-type="bibr">35</xref>].</p>
              <sec id="S25">
                <label>4.1.</label>
                <title>Limitations</title>
                <p id="P33">There are some important limitations to our study. The overarching limitation is the small number of obese older participants enrolled for this proof of principle clinical trial. There was considerable homogeneity amongst the primary variables of body composition, thigh muscle CSA, and physical function even with the small sample size. That being said, we previously mentioned that two individuals were recruited for participation in the Optifast<sup>®</sup> group slightly outside the BMI range (ie., 43 and 44 kg/m<sup>2</sup>). This anomaly may have slightly affected the homogeneity of this variable in the Optifast<sup>®</sup> group. The normality assumption was violated for baseline levels of intrahepatic lipid in the Optifast<sup>®</sup> group. We identified an inadequate normality distribution using the Kolmogorov–Smirnov test and utilized the Wilcoxon Matched-Pairs Signed Ranks test for this particular outcome variable. It is also important to clarify that EMR provided 1/3 more total protein through the provision of individual essential amino acids and intact protein compared to Optifast<sup>®</sup>. Future studies will increase the sample size of our participants, monitor physical activity, and evaluate alcohol consumption that may be responsible for high levels of intrahepatic lipid [<xref rid="R36" ref-type="bibr">36</xref>]. Assessment of these parameters in future studies with higher numbers of participants using an intent to treat approach will also improve the overall interpretation of our approach.</p>
              </sec>
            </sec>
            <sec id="S26">
              <label>5.</label>
              <title>Conclusion</title>
              <p id="P34">The EMR approach is unique in that the anabolic influence of the EAAs can be maximized within the context of a single meal instead of multiple feedings throughout the day. The positive benefits of EMR among our older participants reported herein should be interpreted in the context of per protocol analytical approach which evaluates treatments under optimal conditions. Nevertheless, it is our assertion that structured interventions and/or alternatives to the utilization of EMR are time-consuming and tedious with limited pragmatic application in this cohort. These approaches seem to offer relatively modest benefits despite high financial costs and the need for direct clinical supervision [<xref rid="R37" ref-type="bibr">37</xref>]. Daily provision of EMR for just one month promoted a net gain of thigh muscle CSA, as well as significant reductions in total fat mass, visceral fat mass, and visceral fat volume. The provision of EMR also seemed to improve walking speed, which has been directly associated with reduced mortality and disability [<xref rid="R38" ref-type="bibr">38</xref>,<xref rid="R39" ref-type="bibr">39</xref>]. With respect to the limitations mentioned above, EMR may provide health benefits without the need for complicated and expensive medically supervised interventions.</p>
            </sec>
          </body>
          <back>
            <ack id="S27">
              <title>Acknowledgments</title>
              <p id="P35">Conceptualization, R.R.W. and R.H.C.; Methodology, M.S.C., R.R.W., and R.H.C.; Formal Analysis, M.S.C., Z.B., C.J.M., T.B., B.R.N., and R.H.C.; Investigation, M.S.C., C.J.M., B.R.N., and R.H.C; Data Curation, M.S.C., C.J.M., B.R.N., and R.H.C, Writing-original draft preparation, M.S.C. and R.H.C; Writing-review and editing, M.S.C., C.J.M., R.R.W., and R.H.C; Project Administration, M.S.C., T.B. and R.H.C.; Funding Acquisition; R.R.W. and R.H.C. All authors have read and agreed to the published version of the manuscript. We recognize Katie Axelarris, Kaylee Ladd, Claire Hughes, Michelle Johannsen and Jared Wood for their technical contributions. We would like to express our sincere appreciation to our participants from the Fairbanks area that volunteered their time and effort for this study.</p>
              <sec id="S28">
                <title>Funding</title>
                <p id="P36">Research reported in this publication was supported by Essential Blends, LLC. This research was also supported in part by the National Institute of General Medical Sciences of the National Institutes of Health under award P20GM130443 (Center for Transformative Research in Metabolism) and P20GM103395 (Alaska INBRE). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The University of Alaska Fairbanks, University of Arkansas for Medical Sciences, University of Montana, and James Madison University are affirmative action/equal employment opportunity employers and educational institutions.</p>
              </sec>
            </ack>
            <fn-group>
              <fn fn-type="COI-statement" id="FN1">
                <p id="P37">Conflict of Interest</p>
                <p id="P38">R. Coker and R. Wolfe are Managing Partners and Co-Owners of Essential Blends, LLC that have received funding through the Small Business Innovations in Research from the National Institutes of Health to develop clinical nutrition products. We declare that the results of the study are presented clearly, honestly, and without fabrication, falsification, or inappropriate data manipulation.</p>
              </fn>
            </fn-group>
            <glossary>
              <title>Abbreviations:</title>
              <def-list>
                <def-item>
                  <term>BMI</term>
                  <def>
                    <p id="P39">Body mass index</p>
                  </def>
                </def-item>
                <def-item>
                  <term>CSA</term>
                  <def>
                    <p id="P40">Cross sectional area</p>
                  </def>
                </def-item>
                <def-item>
                  <term>DXA</term>
                  <def>
                    <p id="P41">Dual energy x-ray absorptiometry</p>
                  </def>
                </def-item>
                <def-item>
                  <term>EMR</term>
                  <def>
                    <p id="P42">Experimental meal replacement</p>
                  </def>
                </def-item>
                <def-item>
                  <term>EAA</term>
                  <def>
                    <p id="P43">Essential amino acids</p>
                  </def>
                </def-item>
                <def-item>
                  <term>HDL</term>
                  <def>
                    <p id="P44">High density lipoprotein</p>
                  </def>
                </def-item>
                <def-item>
                  <term>ISRCTRN</term>
                  <def>
                    <p id="P45">International Stand Randomised Controlled Trial Number</p>
                  </def>
                </def-item>
                <def-item>
                  <term>LDL</term>
                  <def>
                    <p id="P46">Low density lipoprotein</p>
                  </def>
                </def-item>
                <def-item>
                  <term>MRI/MRS</term>
                  <def>
                    <p id="P47">Magnetic resonance imaging/magnetic resonance spectroscopy</p>
                  </def>
                </def-item>
                <def-item>
                  <term>NAFLD</term>
                  <def>
                    <p id="P48">Non-alcoholic fatty liver disease</p>
                  </def>
                </def-item>
                <def-item>
                  <term>UAF</term>
                  <def>
                    <p id="P49">University of Alaska Fairbanks</p>
                  </def>
                </def-item>
              </def-list>
            </glossary>
            <ref-list>
              <title>References</title>
              <ref id="R1">
                <label>[1]</label>
                <mixed-citation publication-type="journal"><name><surname>Evans</surname><given-names>WJ</given-names></name>. <article-title>What is sarcopenia?</article-title><source>J Gerontol A Biol Sci</source><year>1995</year>;<volume>50</volume>:<fpage>5</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1093/gerona/50a.special_issue.5</pub-id>.</mixed-citation>
              </ref>
              <ref id="R2">
                <label>[2]</label>
                <mixed-citation publication-type="journal"><name><surname>Cauley</surname><given-names>JA</given-names></name>. <article-title>An overview of sarcopenic obesity</article-title>. <source>J Clin Densitom</source><year>2015</year>;<volume>18</volume>(<issue>4</issue>):<fpage>499</fpage>–<lpage>505</lpage>. <pub-id pub-id-type="doi">10.1016/j.jocd.2015.04.013</pub-id>.<pub-id pub-id-type="pmid">26141163</pub-id></mixed-citation>
              </ref>
              <ref id="R3">
                <label>[3]</label>
                <mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>J</given-names></name>, <name><surname>Hong</surname><given-names>YP</given-names></name>, <name><surname>Shin</surname><given-names>HJ</given-names></name>, <name><surname>Lee</surname><given-names>W</given-names></name>. <article-title>Associations of sarcopenia and sarcopenic obesity with metabolic syndrome considering both muscle mass and muscle strength</article-title>. <source>J Prev Public Health</source><year>2016</year>;<volume>49</volume>(<issue>1</issue>):<fpage>35</fpage>–<lpage>44</lpage>. <pub-id pub-id-type="doi">10.3961/jpmph.15.055</pub-id>.</mixed-citation>
              </ref>
              <ref id="R4">
                <label>[4]</label>
                <mixed-citation publication-type="journal"><name><surname>Alalwan</surname><given-names>TA</given-names></name>. <article-title>Phenotypes of sarcopenic obesity: exploring the effects on perimuscular fat, the obesity paradox, hormone-related responses and the clinical implications</article-title>. <source>Geriatrics</source><year>2020</year>;<volume>5</volume>(<issue>1</issue>):<fpage>8</fpage>. <pub-id pub-id-type="doi">10.3390/geriatrics5010008</pub-id>.<pub-id pub-id-type="pmid">32075166</pub-id></mixed-citation>
              </ref>
              <ref id="R5">
                <label>[5]</label>
                <mixed-citation publication-type="journal"><name><surname>Coker</surname><given-names>RH</given-names></name>, <name><surname>Wolfe</surname><given-names>RR</given-names></name>. <article-title>Weight loss strategies in the elderly: a clinical conundrum</article-title>. <source>Obesity</source><year>2018</year>;<volume>26</volume>(<issue>1</issue>):<fpage>22</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1002/oby.21961</pub-id>.<pub-id pub-id-type="pmid">29265771</pub-id></mixed-citation>
              </ref>
              <ref id="R6">
                <label>[6]</label>
                <mixed-citation publication-type="journal"><name><surname>Weiss</surname><given-names>EC</given-names></name>, <name><surname>Galuska</surname><given-names>DA</given-names></name>, <name><surname>Khan</surname><given-names>LK</given-names></name>, <name><surname>Serdula</surname><given-names>MK</given-names></name>. <article-title>Weight-control practices among U.S. adults, 2001–2002</article-title>. <source>Am J Prev Med</source><year>2006</year>;<volume>31</volume>(<issue>1</issue>):<fpage>18</fpage>–<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1016/j.amepre.2006.03.016</pub-id>.<pub-id pub-id-type="pmid">16777538</pub-id></mixed-citation>
              </ref>
              <ref id="R7">
                <label>[7]</label>
                <mixed-citation publication-type="journal"><name><surname>Borkent</surname><given-names>JW</given-names></name>, <name><surname>Naumann</surname><given-names>E</given-names></name>, <name><surname>Vasse</surname><given-names>E</given-names></name>, <name><surname>van der Heijden</surname><given-names>E</given-names></name>, <article-title>de van der Schueren MAE. Prevalence and determinants of undernutrition in a sample of Dutch community-dwelling older adults: results from two online screening tools</article-title>. <source>Int J Environ Res Publ Health</source><year>2019</year>;<volume>16</volume>(<issue>9</issue>):<fpage>1562</fpage>. <pub-id pub-id-type="doi">10.3390/ijerph16091562</pub-id>.</mixed-citation>
              </ref>
              <ref id="R8">
                <label>[8]</label>
                <mixed-citation publication-type="journal"><name><surname>Keller</surname><given-names>HH</given-names></name>. <article-title>Promoting food intake in older adults living in the community: a review</article-title>. <source>Appl Physiol Nutr Metabol</source><year>2007</year>;<volume>32</volume>(<issue>6</issue>):<fpage>991</fpage>–<lpage>1000</lpage>. <pub-id pub-id-type="doi">10.1139/H07-067</pub-id>.</mixed-citation>
              </ref>
              <ref id="R9">
                <label>[9]</label>
                <mixed-citation publication-type="journal"><name><surname>Payette</surname><given-names>H</given-names></name>, <name><surname>Boutier</surname><given-names>V</given-names></name>, <name><surname>Coulombe</surname><given-names>C</given-names></name>, <name><surname>Gray-Donald</surname><given-names>K</given-names></name>. <article-title>Benefits of nutritional supplementation in free-living, frail, undernourished elderly people: a prospective randomized community trial</article-title>. <source>J Am Diet Assoc</source><year>2002</year>;<volume>102</volume>(<issue>8</issue>):<fpage>1088</fpage>–<lpage>95</lpage>.<pub-id pub-id-type="pmid">12171453</pub-id></mixed-citation>
              </ref>
              <ref id="R10">
                <label>[10]</label>
                <mixed-citation publication-type="journal"><name><surname>Heymsfield</surname><given-names>SB</given-names></name>, <name><surname>Van Mierlo</surname><given-names>CAJ</given-names></name>, <name><surname>Van Der Knaap</surname><given-names>HCM</given-names></name>, <name><surname>Heo</surname><given-names>M</given-names></name>, <name><surname>Frier</surname><given-names>HI</given-names></name>. <article-title>Weight management using a meal replacement strategy: meta and pooling analysis from six studies</article-title>. <source>Int J Obes Metab Disorders</source><year>2003</year>;<volume>27</volume>(<issue>5</issue>):<fpage>537</fpage>–<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1038/sj.ijo.0802258</pub-id>.</mixed-citation>
              </ref>
              <ref id="R11">
                <label>[11]</label>
                <mixed-citation publication-type="journal"><name><surname>Wilkinson</surname><given-names>DJ</given-names></name>, <name><surname>Piasecki</surname><given-names>M</given-names></name>, <name><surname>Atherton</surname><given-names>PJ</given-names></name>. <article-title>The age-related loss of skeletal muscle mass and function: measurement and physiology of muscle fibre atrophy and muscle fibre loss in humans</article-title>. <source>Ageing Res Rev</source><year>2018</year>;<volume>47</volume>:<fpage>123</fpage>–<lpage>32</lpage>.<pub-id pub-id-type="pmid">30048806</pub-id></mixed-citation>
              </ref>
              <ref id="R12">
                <label>[12]</label>
                <mixed-citation publication-type="journal"><name><surname>Coker</surname><given-names>MS</given-names></name>, <name><surname>Ladd</surname><given-names>KR</given-names></name>, <name><surname>Kim</surname><given-names>J</given-names></name>, <name><surname>Murphy</surname><given-names>CJ</given-names></name>, <name><surname>DeCort</surname><given-names>R</given-names></name>, <name><surname>Newcomer</surname><given-names>BR</given-names></name>, <etal/><article-title>Essential amino acid supplement lowers intrahepatic lipid despite excess alcohol consumption</article-title>. <source>Nutrients</source><year>2020</year>;<volume>12</volume>(<issue>1</issue>):<fpage>254</fpage>. <pub-id pub-id-type="doi">10.3390/nu12010254</pub-id>.<pub-id pub-id-type="pmid">31963802</pub-id></mixed-citation>
              </ref>
              <ref id="R13">
                <label>[13]</label>
                <mixed-citation publication-type="journal"><name><surname>Coker</surname><given-names>RH</given-names></name>, <name><surname>Shin</surname><given-names>K</given-names></name>, <name><surname>Scholten</surname><given-names>K</given-names></name>, <name><surname>Johannsen</surname><given-names>M</given-names></name>, <name><surname>Tsigonis</surname><given-names>J</given-names></name>, <name><surname>Kim</surname><given-names>I-Y</given-names></name>, <etal/><article-title>Essential amino acid-enriched meal replacement promotes superior net protein balance in older, overweight adults</article-title>. <source>Clin Nutr</source><year>2019</year>;<volume>38</volume>(<issue>6</issue>):<fpage>2821</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.clnu.2018.12.013</pub-id>.<pub-id pub-id-type="pmid">30638738</pub-id></mixed-citation>
              </ref>
              <ref id="R14">
                <label>[14]</label>
                <mixed-citation publication-type="journal"><name><surname>Coker</surname><given-names>RH</given-names></name>, <name><surname>Hays</surname><given-names>NP</given-names></name>, <name><surname>Williams</surname><given-names>RH</given-names></name>, <name><surname>Wolfe</surname><given-names>RR</given-names></name>, <name><surname>Evans</surname><given-names>WJ</given-names></name>. <article-title>Bed rest promotes reductions in walking speed, functional parameters, and aerobic fitness in older, healthy adults</article-title>. <source>J Gerontol A Biol Sci</source><year>2015</year>;<volume>70</volume>(<issue>1</issue>):<fpage>91</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1093/gerona/glu123</pub-id>.</mixed-citation>
              </ref>
              <ref id="R15">
                <label>[15]</label>
                <mixed-citation publication-type="journal"><name><surname>Ahedi</surname><given-names>H</given-names></name>, <name><surname>Aitken</surname><given-names>D</given-names></name>, <name><surname>Scott</surname><given-names>D</given-names></name>, <name><surname>Blizzard</surname><given-names>L</given-names></name>, <name><surname>Cicuttini</surname><given-names>F</given-names></name>, <name><surname>Jones</surname><given-names>G</given-names></name>. <article-title>The association between hip muscle cross-sectional area, muscle strength, and bone mineral density</article-title>. <source>Calcif Tissue Int</source><year>2014</year>;<volume>95</volume>(<issue>1</issue>):<fpage>64</fpage>–<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1007/s00223-014-9863-6</pub-id>.<pub-id pub-id-type="pmid">24829114</pub-id></mixed-citation>
              </ref>
              <ref id="R16">
                <label>[16]</label>
                <mixed-citation publication-type="journal"><name><surname>Faul</surname><given-names>F</given-names></name>, <name><surname>Erdfelder</surname><given-names>E</given-names></name>, <name><surname>Lang</surname><given-names>A-G</given-names></name>, <name><surname>Buchner</surname><given-names>AG</given-names></name>. <article-title>*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences</article-title>. <source>Behav Res Methods</source><year>2007</year>;<volume>39</volume>:<fpage>175</fpage>–<lpage>91</lpage>. <pub-id pub-id-type="doi">10.3758/bf03193146</pub-id>.<pub-id pub-id-type="pmid">17695343</pub-id></mixed-citation>
              </ref>
              <ref id="R17">
                <label>[17]</label>
                <mixed-citation publication-type="journal"><name><surname>Coker</surname><given-names>RH</given-names></name>, <name><surname>Miller</surname><given-names>S</given-names></name>, <name><surname>Schutzler</surname><given-names>SE</given-names></name>, <name><surname>Deutz</surname><given-names>NEP</given-names></name>, <name><surname>Wolfe</surname><given-names>RR</given-names></name>. <article-title>Whey protein and essential amino acids promote the reduction of adipose tissue and increased muscle protein synthesis during caloric restriction-induced weight loss in elderly, obese individuals</article-title>. <source>Nutr J</source><year>2012</year>;<volume>11</volume>:<fpage>105</fpage>. <pub-id pub-id-type="doi">10.1186/1475-2891-11-105</pub-id>.<pub-id pub-id-type="pmid">23231757</pub-id></mixed-citation>
              </ref>
              <ref id="R18">
                <label>[18]</label>
                <mixed-citation publication-type="journal"><name><surname>Breen</surname><given-names>L</given-names></name>, <name><surname>Phillips</surname><given-names>SM</given-names></name>. <article-title>Skeletal muscle protein metabolism in the elderly: interventions to counteract the ‘anabolic resistance’ of ageing</article-title>. <source>Nutr Metab</source><year>2011</year>;<volume>8</volume>:<fpage>68</fpage>. <pub-id pub-id-type="doi">10.1186/1743-7075-8-68</pub-id>.</mixed-citation>
              </ref>
              <ref id="R19">
                <label>[19]</label>
                <mixed-citation publication-type="journal"><name><surname>Alturki</surname><given-names>M</given-names></name>, <name><surname>Beyer</surname><given-names>I</given-names></name>, <name><surname>Mets</surname><given-names>T</given-names></name>, <name><surname>Bautmans</surname><given-names>I</given-names></name>. <article-title>Impact of drugs with anti-inflammatory effects on skeletal muscle and inflammation: a systematic literature review</article-title>. <source>Exp Gerontol</source><year>2018</year>;<volume>114</volume>:<fpage>33</fpage>–<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1016/j.exger.2018.10.011</pub-id>.<pub-id pub-id-type="pmid">30367977</pub-id></mixed-citation>
              </ref>
              <ref id="R20">
                <label>[20]</label>
                <mixed-citation publication-type="journal"><name><surname>Mitsiopoulos</surname><given-names>N</given-names></name>, <name><surname>Baumgartner</surname><given-names>RN</given-names></name>, <name><surname>Heymsfield</surname><given-names>SB</given-names></name>, <name><surname>Lyons</surname><given-names>W</given-names></name>, <name><surname>Gallagher</surname><given-names>D</given-names></name>, <name><surname>Ross</surname><given-names>R</given-names></name>. <article-title>Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography</article-title>. <source>J Appl Physiol</source><year>1998</year>;<volume>85</volume>(<issue>1</issue>):<fpage>115</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1152/jappl.1998.85.1.115</pub-id>.<pub-id pub-id-type="pmid">9655763</pub-id></mixed-citation>
              </ref>
              <ref id="R21">
                <label>[21]</label>
                <mixed-citation publication-type="journal"><name><surname>Paddon-Jones</surname><given-names>D</given-names></name>, <name><surname>Sheffield-Moore</surname><given-names>M</given-names></name>, <name><surname>Aarsland</surname><given-names>A</given-names></name>, <name><surname>Wolfe</surname><given-names>RR</given-names></name>, <name><surname>Ferrando</surname><given-names>AA</given-names></name>. <article-title>Exogenous amino acids stimulate human muscle anabolism without interfering with the response to mixed meal ingestion</article-title>. <source>Am J Physiol Endocrinol Metab</source><year>2005</year>;<volume>288</volume>(<issue>4</issue>):<fpage>E761</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1152/ajpendo.00291.2004</pub-id>.<pub-id pub-id-type="pmid">15572657</pub-id></mixed-citation>
              </ref>
              <ref id="R22">
                <label>[22]</label>
                <mixed-citation publication-type="journal"><name><surname>Ardali</surname><given-names>G</given-names></name>, <name><surname>Brody</surname><given-names>LT</given-names></name>, <name><surname>States</surname><given-names>RA</given-names></name>, <name><surname>Godwin</surname><given-names>EM</given-names></name>. <article-title>Reliability and validity of the floor transfer test as a measure of readiness for independent living among older adults</article-title>. <source>J Geriatr Phys Ther</source><year>2019</year>;<volume>42</volume>(<issue>3</issue>):<fpage>136</fpage>–<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1519/JPT.0000000000000142</pub-id>.<pub-id pub-id-type="pmid">29059121</pub-id></mixed-citation>
              </ref>
              <ref id="R23">
                <label>[23]</label>
                <mixed-citation publication-type="journal"><name><surname>Kervio</surname><given-names>G</given-names></name>, <name><surname>Carre</surname><given-names>F</given-names></name>, <name><surname>Ville</surname><given-names>NS</given-names></name>. <article-title>Reliability and intensity of the six-minute walk test in healthy elderly subjects</article-title>. <source>Med Sci Sports Exerc</source><year>2003</year>;<volume>35</volume>(<issue>1</issue>):<fpage>169</fpage>–<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1097/00005768-200301000-00025</pub-id>.<pub-id pub-id-type="pmid">12544651</pub-id></mixed-citation>
              </ref>
              <ref id="R24">
                <label>[24]</label>
                <mixed-citation publication-type="journal"><name><surname>Deane</surname><given-names>CS</given-names></name>, <name><surname>Ely</surname><given-names>IA</given-names></name>, <name><surname>Wilkinson</surname><given-names>DJ</given-names></name>, <name><surname>Smith</surname><given-names>K</given-names></name>, <name><surname>Phillips</surname><given-names>BE</given-names></name>, <name><surname>Atherton</surname><given-names>PJ</given-names></name>. <article-title>Dietary protein, exercise, ageing and physical inactivity: interactive influences on skeletal muscle proteostasis</article-title>. <source>Proc Nutr Soc</source><year>2020</year>:<fpage>1</fpage>–<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1017/S0029665120007879</pub-id>.</mixed-citation>
              </ref>
              <ref id="R25">
                <label>[25]</label>
                <mixed-citation publication-type="journal"><name><surname>Wolfe</surname><given-names>RR</given-names></name>. <article-title>The underappreciated role of muscle in health and disease</article-title>. <source>Am J Clin Nutr</source><year>2006</year>;<volume>84</volume>(<issue>3</issue>):<fpage>475</fpage>–<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1093/ajcn/84.3.475</pub-id>.<pub-id pub-id-type="pmid">16960159</pub-id></mixed-citation>
              </ref>
              <ref id="R26">
                <label>[26]</label>
                <mixed-citation publication-type="journal"><name><surname>Bischoff</surname><given-names>SC</given-names></name>, <name><surname>Boirie</surname><given-names>Y</given-names></name>, <name><surname>Cederholm</surname><given-names>T</given-names></name>, <name><surname>Chourdakis</surname><given-names>M</given-names></name>, <name><surname>Cuerda</surname><given-names>C</given-names></name>, <name><surname>Delzenne</surname><given-names>NM</given-names></name>, <etal/><article-title>Towards a multidisciplinary approach to understand and manage obesity and related diseases</article-title>. <source>Clin Nutr</source><year>2017</year>;<volume>36</volume>(<issue>4</issue>):<fpage>917</fpage>–<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1016/j.clnu.2016.11.007</pub-id>.<pub-id pub-id-type="pmid">27890486</pub-id></mixed-citation>
              </ref>
              <ref id="R27">
                <label>[27]</label>
                <mixed-citation publication-type="journal"><name><surname>Patel</surname><given-names>YA</given-names></name>, <name><surname>Berg</surname><given-names>CL</given-names></name>, <name><surname>Moylan</surname><given-names>CA</given-names></name>. <article-title>Nonalcoholic fatty liver disease: key considerations before and after liver transplantation</article-title>. <source>Dig Dis Sci</source><year>2016</year>;<volume>61</volume>(<issue>5</issue>):<fpage>1406</fpage>–<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1007/s10620-016-4035-3</pub-id>.<pub-id pub-id-type="pmid">26815171</pub-id></mixed-citation>
              </ref>
              <ref id="R28">
                <label>[28]</label>
                <mixed-citation publication-type="journal"><name><surname>Børsheim</surname><given-names>E</given-names></name>, <name><surname>Bui</surname><given-names>Q-UT</given-names></name>, <name><surname>Tissier</surname><given-names>S</given-names></name>, <name><surname>Cree</surname><given-names>MG</given-names></name>, <name><surname>Rønson</surname><given-names>O</given-names></name>, <name><surname>Morio</surname><given-names>B</given-names></name>, <etal/><article-title>Amino acid supplementation decreases plasma and liver triacylglycerols in elderly</article-title>. <source>Nutrition</source><year>2009</year>;<volume>25</volume>(<issue>3</issue>):<fpage>281</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.nut.2008.09.001</pub-id>.<pub-id pub-id-type="pmid">19041223</pub-id></mixed-citation>
              </ref>
              <ref id="R29">
                <label>[29]</label>
                <mixed-citation publication-type="journal"><name><surname>Pichon</surname><given-names>L</given-names></name>, <name><surname>Huneau</surname><given-names>JF</given-names></name>, <name><surname>Fromentin</surname><given-names>G</given-names></name>, <name><surname>Tomé</surname><given-names>D</given-names></name>. <article-title>A high-protein, high-fat, carbohydrate-free diet reduces energy intake, hepatic lipogenesis, and adiposity in rats</article-title>. <source>J Nutr</source><year>2006</year>;<volume>136</volume>(<issue>5</issue>):<fpage>1256</fpage>–<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1093/jn/136.5.1256</pub-id>.<pub-id pub-id-type="pmid">16614413</pub-id></mixed-citation>
              </ref>
              <ref id="R30">
                <label>[30]</label>
                <mixed-citation publication-type="journal"><name><surname>van den Berg</surname><given-names>EH</given-names></name>, <name><surname>Flores-Guerrero</surname><given-names>JL</given-names></name>, <name><surname>Gruppen</surname><given-names>EG</given-names></name>, <name><surname>de Borst</surname><given-names>MH</given-names></name>, <name><surname>Wolak-Dinsmore</surname><given-names>J</given-names></name>, <name><surname>Connelly</surname><given-names>MA</given-names></name>, <etal/><article-title>Non-alcoholic fatty liver disease and risk of incident type 2 diabetes: role of circulating branched-chain amino acids</article-title>. <source>Nutrients</source><year>2019</year>;<volume>11</volume>(<issue>3</issue>):<fpage>705</fpage>. <pub-id pub-id-type="doi">10.3390/nu11030705</pub-id>.<pub-id pub-id-type="pmid">30917546</pub-id></mixed-citation>
              </ref>
              <ref id="R31">
                <label>[31]</label>
                <mixed-citation publication-type="journal"><name><surname>Gaggini</surname><given-names>M</given-names></name>, <name><surname>Carli</surname><given-names>F</given-names></name>, <name><surname>Rosso</surname><given-names>C</given-names></name>, <name><surname>Buzzigoli</surname><given-names>E</given-names></name>, <name><surname>Marietti</surname><given-names>M</given-names></name>, <name><surname>Della Latta</surname><given-names>V</given-names></name>, <etal/><article-title>Altered amino acid concentrations in NAFLD: impact of obesity and insulin resistance</article-title>. <source>Hepatology</source><year>2018</year>;<volume>67</volume>(<issue>1</issue>):<fpage>145</fpage>–<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1002/hep.29465</pub-id>.<pub-id pub-id-type="pmid">28802074</pub-id></mixed-citation>
              </ref>
              <ref id="R32">
                <label>[32]</label>
                <mixed-citation publication-type="journal"><name><surname>Newgard</surname><given-names>CB</given-names></name>, <name><surname>An</surname><given-names>J</given-names></name>, <name><surname>Bain</surname><given-names>JR</given-names></name>, <name><surname>Muehlbauer</surname><given-names>MJ</given-names></name>, <name><surname>Stevens</surname><given-names>RD</given-names></name>, <name><surname>Lien</surname><given-names>LF</given-names></name>, <etal/><article-title>A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to ionsulin resistance</article-title>. <source>Cell Metabol</source><year>2009</year>;<volume>9</volume>(<issue>4</issue>):<fpage>311</fpage>–<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2009.02.002</pub-id>.</mixed-citation>
              </ref>
              <ref id="R33">
                <label>[33]</label>
                <mixed-citation publication-type="journal"><name><surname>Iwao</surname><given-names>M</given-names></name>, <name><surname>Gotoh</surname><given-names>K</given-names></name>, <name><surname>Arakawa</surname><given-names>M</given-names></name>, <name><surname>Endo</surname><given-names>M</given-names></name>, <name><surname>Honda</surname><given-names>K</given-names></name>, <name><surname>Seike</surname><given-names>M</given-names></name>, <etal/><article-title>Supplementation of branched-chain amino acids decreases fat accumulation in the liver through intestinal microbiota-mediated production of acetic acid</article-title>. <source>Sci Rep</source><year>2020</year>;<volume>10</volume>(<issue>1</issue>):<fpage>18768</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-020-75542-3</pub-id>.<pub-id pub-id-type="pmid">33127939</pub-id></mixed-citation>
              </ref>
              <ref id="R34">
                <label>[34]</label>
                <mixed-citation publication-type="journal"><name><surname>Vieira</surname><given-names>EES</given-names></name>, <name><surname>Pereira</surname><given-names>IS</given-names></name>, <name><surname>Braz</surname><given-names>AF</given-names></name>, <name><surname>Nascimento-Ferreira</surname><given-names>MV</given-names></name>, <name><surname>de Oliverira Torres</surname><given-names>LR</given-names></name>, <name><surname>de Freitas Brito</surname><given-names>A</given-names></name>, <name><surname>do Nascimento Marrerio</surname><given-names>D</given-names></name>, <name><surname>de Castro</surname><given-names>E</given-names></name>, <name><surname>Sousa</surname><given-names>J</given-names></name>, <name><surname>da Silva</surname><given-names>FCC</given-names></name>, <name><surname>Torres-Leal</surname><given-names>FL</given-names></name>. <article-title>Food consumption of branched chain amino acids and insulin resistance: a systematic review of observational studies in humans</article-title>. <source>Clinical Nutrition ESPEN2020</source>;<volume>40</volume>:<fpage>277</fpage>–<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1016/j.clnesp.2020.09.007</pub-id>.</mixed-citation>
              </ref>
              <ref id="R35">
                <label>[35]</label>
                <mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>I-Y</given-names></name>, <name><surname>Schutzler</surname><given-names>SE</given-names></name>, <name><surname>Azhar</surname><given-names>G</given-names></name>, <name><surname>Wolfe</surname><given-names>RR</given-names></name>, <name><surname>Ferrando</surname><given-names>AA</given-names></name>, <name><surname>Coker</surname><given-names>RH</given-names></name>. <article-title>Short term elevation in dietary protein intake does not worsen insulin resistance or lipids in older adults with metabolic syndrome: a randomized controlled-trial</article-title>. <source>Biomed Central Nutr</source><year>2017</year>;<volume>3</volume>:<fpage>33</fpage>. <pub-id pub-id-type="doi">10.1186/s40795-017-0152-4</pub-id>.</mixed-citation>
              </ref>
              <ref id="R36">
                <label>[36]</label>
                <mixed-citation publication-type="journal"><name><surname>Boyle</surname><given-names>M</given-names></name>, <name><surname>Masson</surname><given-names>S</given-names></name>, <name><surname>Anstee</surname><given-names>QM</given-names></name>. <article-title>The bidirectional impacts of alcohol consumption and the metabolic syndrome: cofactors for progressive fatty liver disease</article-title>. <source>J Hepatol</source><year>2018</year>;<volume>68</volume>(<issue>2</issue>):<fpage>251</fpage>–<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1016/j.jhep.2017.11.006</pub-id>.<pub-id pub-id-type="pmid">29113910</pub-id></mixed-citation>
              </ref>
              <ref id="R37">
                <label>[37]</label>
                <mixed-citation publication-type="journal"><name><surname>Beavers</surname><given-names>KM</given-names></name>, <name><surname>Nesbit</surname><given-names>BA</given-names></name>, <name><surname>Kiel</surname><given-names>JR</given-names></name>, <name><surname>Sheedy</surname><given-names>JL</given-names></name>, <name><surname>Arterburn</surname><given-names>LM</given-names></name>, <name><surname>Collins</surname><given-names>AE</given-names></name>, <etal/><article-title>Effect of an energy-restricted, nutritionally complete, higher protein meal plan on body composition and mobility in older adults with obesity: a randomized controlled trial</article-title>. <source>J Gerontol A Biol Sci</source><year>2019</year>;<volume>74</volume>(<issue>6</issue>):<fpage>929</fpage>–<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1093/gerona/gly146</pub-id>.</mixed-citation>
              </ref>
              <ref id="R38">
                <label>[38]</label>
                <mixed-citation publication-type="journal"><name><surname>Zanker</surname><given-names>J</given-names></name>, <name><surname>Patel</surname><given-names>S</given-names></name>, <name><surname>Blackwell</surname><given-names>T</given-names></name>, <name><surname>Duchowny</surname><given-names>K</given-names></name>, <name><surname>Brennan-Olsen</surname><given-names>S</given-names></name>, <name><surname>Evans</surname><given-names>WJ</given-names></name>, <etal/><article-title>Osteoporotic Fractures in Men (MRoS) Study Group. Walking speed and muscle mass estimated by the D3-creatine dilution method are important components of sarcopenia associated with incident mobility disability in older men: a classification and regression tree analysis</article-title>. <source>J Am Med Dir Assoc</source><year>2020</year>;<volume>21</volume>(<issue>12</issue>):<fpage>1997</fpage>–<lpage>2002</lpage>. <pub-id pub-id-type="doi">10.1016/j.jamda.2020.03.017</pub-id>.<pub-id pub-id-type="pmid">32381425</pub-id></mixed-citation>
              </ref>
              <ref id="R39">
                <label>[39]</label>
                <mixed-citation publication-type="journal"><name><surname>Studenski</surname><given-names>S</given-names></name>, <name><surname>Perera</surname><given-names>S</given-names></name>, <name><surname>Patel</surname><given-names>K</given-names></name>, <name><surname>Rosano</surname><given-names>C</given-names></name>, <name><surname>Faulkner</surname><given-names>K</given-names></name>, <name><surname>Inzitari</surname><given-names>M</given-names></name>, <etal/><article-title>Gait speed and survival in older adults</article-title>. <source>J Am Med Assoc</source><year>2011</year>;<volume>305</volume>(<issue>1</issue>):<fpage>50</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1001/jama.2010.1923</pub-id>.</mixed-citation>
              </ref>
            </ref-list>
          </back>
          <floats-group>
            <fig position="float" id="F1">
              <label>Fig. 1.</label>
              <caption>
                <p id="P50">CONSORT flow diagram.</p>
              </caption>
              <graphic xlink:href="nihms-1884232-f0001" position="float"/>
            </fig>
            <fig position="float" id="F2">
              <label>Fig. 2.</label>
              <caption>
                <p id="P51">Change in Thigh muscle CSA.</p>
              </caption>
              <graphic xlink:href="nihms-1884232-f0002" position="float"/>
            </fig>
            <fig position="float" id="F3">
              <label>Fig. 3.</label>
              <caption>
                <p id="P52">Intrahepatic in Optifast and EMR.</p>
              </caption>
              <graphic xlink:href="nihms-1884232-f0003" position="float"/>
            </fig>
            <table-wrap position="float" id="T1">
              <label>Table 1</label>
              <caption>
                <p id="P53">Nutritional composition of meal replacements.</p>
              </caption>
              <table frame="hsides" rules="none">
                <colgroup span="1">
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                </colgroup>
                <thead>
                  <tr>
                    <th align="left" valign="top" rowspan="1" colspan="1">Macronutrients</th>
                    <th align="left" valign="top" rowspan="1" colspan="1">EMR (grams)</th>
                    <th align="left" valign="top" rowspan="1" colspan="1">EMR (calories)</th>
                    <th align="left" valign="top" rowspan="1" colspan="1">Optifast<sup>®</sup> (grams)</th>
                    <th align="left" valign="top" rowspan="1" colspan="1">Optifast<sup>®</sup> (calories)</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td colspan="5" align="left" valign="top" rowspan="1">
                      <hr/>
                    </td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">EAA’s</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">16</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">66</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">0</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">0</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Protein</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">6</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">24</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">16</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">66</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Fat</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">3</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">27</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">4</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">32</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Carbohydrate</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">11</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">45</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">15</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">62</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Total</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">36</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">162</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">40</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">160</td>
                  </tr>
                </tbody>
              </table>
            </table-wrap>
            <table-wrap position="float" id="T2">
              <label>Table 2</label>
              <caption>
                <p id="P54">Clinical characteristics.</p>
              </caption>
              <table frame="hsides" rules="none">
                <colgroup span="1">
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                </colgroup>
                <thead>
                  <tr>
                    <th align="left" valign="top" rowspan="1" colspan="1"/>
                    <th align="left" valign="top" rowspan="1" colspan="1">EMR (pre)</th>
                    <th align="left" valign="top" rowspan="1" colspan="1">EMR (post)</th>
                    <th align="left" valign="top" rowspan="1" colspan="1">Optifast<sup>®</sup> (pre)</th>
                    <th align="left" valign="top" rowspan="1" colspan="1">Optifast<sup>®</sup> (post)</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td colspan="5" align="left" valign="top" rowspan="1">
                      <hr/>
                    </td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Age (years)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">67.3 ± 4.9</td>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                    <td align="left" valign="top" rowspan="1" colspan="1">69.2 ± 5.3</td>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Sex (m/f)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">6/8</td>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                    <td align="left" valign="top" rowspan="1" colspan="1">6/9</td>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Body mass (kg)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">86.8 ± 9.1</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">86.0 ± 9.0</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">92.7 ± 18.8</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">91.8 ± 17.8</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Body mass index (kg/m2)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">30.8 ± 2.3</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">30.5 ± 0.6</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">33.7 ± 5.0</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">33.3 ± 4.8</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Waist Hip Ratio</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">0.93 ± 0.09</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">0.94 ± 0.09</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">0.93 ± 0.10</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">0.93 ± 0.09</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">
                      <bold>Body composition</bold>
                    </td>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                    <td align="left" valign="top" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Body Fat (%)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">40 ± 7</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">39 ± 7</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">41 ± 8</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">41 ± 8</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Adipose Tissue Mass (kg)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">33 ± 6</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">32 ± 5<xref rid="TFN2" ref-type="table-fn">*</xref></td>
                    <td align="left" valign="top" rowspan="1" colspan="1">36 ± 10</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">33 ± 8</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Visceral Adipose Tissue Mass (kg)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">1.8 ± 0.1</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">1.7 ± 0.1<xref rid="TFN2" ref-type="table-fn">*</xref></td>
                    <td align="left" valign="top" rowspan="1" colspan="1">1.9 ± 1.5</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">1.5 ± 1.2</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Visceral Adipose Tissue Volume (cm<sup>3</sup>)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">1863 ± 971</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">1755 ± 962<xref rid="TFN2" ref-type="table-fn">*</xref></td>
                    <td align="left" valign="top" rowspan="1" colspan="1">2029 ± 1611</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">2005 ± 1443</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Android Adipose Tissue (%)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">48 ± 8</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">47 ± 7</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">47 ± 9</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">45 ± 9</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Gynoid Adipose Tissue (%)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">39 ± 9</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">39 ± 8</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">41 ± 10</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">41 ± 10</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Android/Gynoid Ratio</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">1.2 ± 0.2</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">1.2 ± 0.2</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">1.2 ± 0.3</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">1.2 ± 0.3</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Trunk Adipose Tissue (%)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">44 ± 7</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">43 ± 6</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">43 ± 7</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">41 ± 7</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Arm Adipose Tissue (%)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">36 ± 10</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">36 ± 10</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">37 ± 10</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">36 ± 10</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Leg Adipose Tissue (%)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">33 ± 10</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">33 ± 10</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">38 ± 11</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">38 ± 12</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Lean Tissue Mass (kg)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">51 ± 10</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">51 ± 9</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">52 ± 12</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">52 ± 12</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Bone mineral density (g/cm<sup>2</sup>)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">1.3 ± 0.1</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">1.3 ± 0.2</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">1.3 ± 0.1</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">1.2 ± 0.2</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="TFN1">
                  <p id="P55">Data are presented as means ± SD.</p>
                </fn>
                <fn id="TFN2">
                  <label>*</label>
                  <p id="P56">Denotes significant reduction (P &lt; 0.05).</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <table-wrap position="float" id="T3">
              <label>Table 3</label>
              <caption>
                <p id="P57">Physical function.</p>
              </caption>
              <table frame="hsides" rules="none">
                <colgroup span="1">
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                </colgroup>
                <thead>
                  <tr>
                    <th align="left" valign="top" rowspan="1" colspan="1"/>
                    <th align="left" valign="top" rowspan="1" colspan="1">EMR (pre)</th>
                    <th align="left" valign="top" rowspan="1" colspan="1">EMR (post)</th>
                    <th align="left" valign="top" rowspan="1" colspan="1">Optifast<sup>®</sup> (pre)</th>
                    <th align="left" valign="top" rowspan="1" colspan="1">Optifast<sup>®</sup> (post)</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td colspan="5" align="left" valign="top" rowspan="1">
                      <hr/>
                    </td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Right Arm Grip Strength (kg)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">37 ± 10</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">39 ± 9</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">34 ± 10</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">36 ± 11</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Left Hand Grip Strength (kg)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">37 ± 11</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">36 ± 11</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">34 ± 13</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">36 ± 13</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Floor Transfer Test (sec)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">8.8 ± 2.9</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">7.8 ± 2.2*</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">14.7 ± 11.7</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">11.2 ± 7.4</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Six Minute Walk distance (m)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">554 ± 67</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">578 ± 73*</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">541 ± 128</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">563 ± 113</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Walking Speed (m/sec)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">1.5 ± 0.2</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">1.6 ± 0.2*</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">1.5 ± 0.4</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">1.6 ± 0.3</td>
                  </tr>
                </tbody>
              </table>
            </table-wrap>
            <table-wrap position="float" id="T4">
              <label>Table 4</label>
              <caption>
                <p id="P58">Blood parameters.</p>
              </caption>
              <table frame="hsides" rules="none">
                <colgroup span="1">
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                  <col align="left" valign="middle" span="1"/>
                </colgroup>
                <thead>
                  <tr>
                    <th align="left" valign="top" rowspan="1" colspan="1"/>
                    <th align="left" valign="top" rowspan="1" colspan="1">EMR (pre)</th>
                    <th align="left" valign="top" rowspan="1" colspan="1">EMR (post)</th>
                    <th align="left" valign="top" rowspan="1" colspan="1">Optifast<sup>®</sup> (pre)</th>
                    <th align="left" valign="top" rowspan="1" colspan="1">Optifast<sup>®</sup> (post)</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td colspan="5" align="left" valign="top" rowspan="1">
                      <hr/>
                    </td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Total cholesterol (mg/dl)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">177 ± 34</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">176 ± 28</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">197 ± 34</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">186 ± 41</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">HDL cholesterol (mg/dl)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">55 ± 16</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">54 ± 14</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">59 ± 15</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">61 ± 14</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">LDL cholesterol (mg/dl)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">100 ± 28</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">101 ±26</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">118 ± 32</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">108 ± 34</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Triglycerides (mg/dl)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">110 ± 54</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">106 ± 57</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">98 ± 36</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">87 ± 40</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Protein (g/dL)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">6.6 ± 0.3</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">6.8 ± 0.3<xref rid="TFN4" ref-type="table-fn">*</xref></td>
                    <td align="left" valign="top" rowspan="1" colspan="1">6.7 ± 0.4</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">6.8 ± 0.4</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Albumin (g/dL)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">4.3 ± 0.2</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">4.4 ± 0.2<xref rid="TFN4" ref-type="table-fn">*</xref></td>
                    <td align="left" valign="top" rowspan="1" colspan="1">4.2 ± 0.2</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">4.3 ± 0.2</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Total Bilirubin (g/dL)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">0.5 ± 0.3</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">0.4 ± 0.3</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">0.5 ± 0.3</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">0.5 ± 0.3</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Direct Bilirubin (g/dL)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">0.1 ± 0.1</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">0.1 ± 0.1</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">0.1 ± 0.1</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">0.1 ± 0.1</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Alkaline Phosphatase (IU/L)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">70 ± 16</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">68 ± 17</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">71 ± 15</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">70 ± 15</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Aspartate Aminotransferase (IU/L)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">21 ± 4</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">22 ± 3</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">24 ± 7</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">24 ± 4</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Alanine Aminotransferase (IU/L)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">21 ± 5</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">20 ± 6</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">22 ± 10</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">21 ± 7</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Glucose (mg/dL)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">94 ± 14</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">100 ± 29</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">102 ± 50</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">93 ± 10</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Blood Urea Nitrogen (mg/dL)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">18 ± 6</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">22 ± 6<xref rid="TFN4" ref-type="table-fn">*</xref></td>
                    <td align="left" valign="top" rowspan="1" colspan="1">19 ± 4</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">20 ± 5</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Creatinine (mg/dL)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">0.8 ± 0.1</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">0.9 ± 0.2</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">0.9 ± 0.2</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">0.9 ± 0.2</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">BUN/Creatinine</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">21 ± 6</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">24 ± 5</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">21 ± 4</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">22 ± 5</td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">eGFR (mL/min/1.73)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">81 ± 14</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">76 ± 14</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">74 ± 13</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">75 ± 16</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="TFN3">
                  <p id="P59">Data are presented as means ± SD.</p>
                </fn>
                <fn id="TFN4">
                  <label>*</label>
                  <p id="P60">Denotes significant change from baseline (<italic toggle="yes">P</italic> &lt; 0.05).</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </floats-group>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
